Effects of nasal inflammation on the olfactory bulb
Description
No abstract
PubMed COVID-19 Clinical Care
4751 - 4760 of 4858 results found
Effective strategies against COVID-19 and the importance of infection sequelae
Description
No abstract
Evaluation of potential drug-drug interactions and polypharmacy in hospitalized COVID-19 patients
Description
CONCLUSIONS: Clinically important pDDIs are common among COVID-19 patients and the majority of pDDIs require monitoring of therapy. COVID-19 patients should be closely observed for QT prolongation, hypoglycemia, and hemorrhage due to pDDIs during
Epigenetic and transcriptomic reprogramming in monocytes of severe COVID-19 patients reflects alterations in myeloid differentiation and the influence of inflammatory cytokines
Description
CONCLUSION: Our findings show the occurrence of an epigenetic and transcriptional reprogramming of peripheral blood monocytes, which could be associated with the release of aberrant immature monocytes, increased systemic levels of pro-inflammatory
Effectiveness of a community-integrated intermediary care (CIIC) service model to enhance family-based long-term care for Thai older adults in Chiang Mai, Thailand: a cluster-randomized controlled trial TCTR20190412004
Description
CONCLUSIONS: When communities are integrated for preventing care, and families are empowered for giving care, it is possible to secure universal access to health and social care for the older persons, with basic resources mobilized from communities
Epidemiological evaluation of mass testing in a small municipality in the Netherlands during the SARS-CoV-2 epidemic
Description
During 6 weeks in February-March 2021, the Dutch municipal health service Utrecht studied the epidemiological effects on test incidence and the detection of acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with mass testing (MT). During MT
Effect of BNT162b2 mRNA booster vaccination on VO2 max in recreational athletes: A prospective cohort study
Description
CONCLUSION: In our population of recreational endurance athletes, booster vaccination with the BNT162b2 mRNA vaccine resulted in a statistically significant decrease in VO(2max) 7 days after vaccination. The clinical impact hereof needs to be further